Whole Exome Sequencing Market, By Product Type, By Technology, By Application, By Indication, By End User, By Geography

Description

The global whole exome sequencing market is estimated to be valued at USD 1.80 Bn in 2024 and is expected to reach USD 4.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.80 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.80%	2031 Value Projection:	US$ 4.72 Bn

Figure. Whole Exome Sequencing Market Share (%), By Region 2024

Whole exome sequencing is a powerful technology that allows analyzing the entire protein-coding region of genes in order to detect genetic variations responsible for diseases. It has revolutionized clinical diagnosis and genetic research in recent years. Whole exome sequencing market is expected to experience significant growth due to rising applications in cancer research, increasing demand for personalized medicine, and growing popularity of whole genome sequencing over traditional sequencing techniques.

Market Dynamics:

The global whole exome sequencing market is driven by rising incidence of chronic diseases, increased funding for research activities, growing applicability of whole exome sequencing in drug discovery, and precision medicine. However, budget constraints, requirement of skilled personnel and non-availability of adequate reimbursement policies limit the market growth. The market provides opportunities for players due to emerging economies, continuous technological advancements, and increasing collaborations between industry and academia.

Key Features of the Study:

This report provides in-depth analysis of the global whole exome sequencing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global whole exome sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics, Agilent Technologies, Inc., Roche Diagnostics, QIAGEN N.V., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Eurofins Scientific SE, Genomatix GmbH, Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, and Novogene Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global whole exome sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole exome sequencing market

Market Segmentation

By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Instruments
- Consumables
- Services
By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Drug Discovery & Development
- Clinical Diagnostics
- Research
By Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Rare/Inherited Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation

Product Code: CMI7571

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Whole Exome Sequencing Market, By Product Type
- Global Whole Exome Sequencing Market, By Technology
- Global Whole Exome Sequencing Market, By Application
- Global Whole Exome Sequencing Market, By Indication
- Global Whole Exome Sequencing Market, By End User
- Global Whole Exome Sequencing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Whole Exome Sequencing Market, By Product Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Whole Exome Sequencing Market, By Technology, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Sequencing by Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ion Semiconductor Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Whole Exome Sequencing Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Whole Exome Sequencing Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rare/Inherited Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Whole Exome Sequencing Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Whole Exome Sequencing Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
Roche Diagnostics
QIAGEN N.V.
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies plc
Eurofins Scientific SE
Genomatix GmbH
Myriad Genetics, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Novogene Corporation

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us